Clinical Relevance and Management of "Pre-Interstitial Lung Disease"

Area of Science:

• Pulmonology
• Radiology
• Oncology

Background:

• Cellular changes leading to interstitial lung disease (ILD) can occur years before clinical manifestation, termed preclinical ILD.
• Interstitial lung abnormalities (ILA) are frequently detected incidentally on chest computed tomographic (CT) scans, often performed for lung cancer screening.
• ILA represent an early, subclinical stage of lung pathology with significant health implications.

Purpose of the Study:

• To highlight the clinical significance of incidentally identified interstitial lung abnormalities (ILA).
• To underscore the association of ILA with adverse health outcomes.
• To inform current management strategies for individuals with ILA.

Main Methods:

• Review of findings from chest CT scans.
• Analysis of clinical data and radiological features.
• Correlation of ILA presence with patient outcomes.

Main Results:

• Individuals with ILA show an increased risk of mortality.
• ILA are associated with accelerated lung function decline.
• A higher incidence of lung cancer is observed in individuals with ILA.

Conclusions:

• Interstitial lung abnormalities (ILA) are a critical finding on chest CT scans, signaling preclinical interstitial lung disease (ILD).
• Management should focus on identifying high-risk individuals with ILA based on clinical and radiological factors to mitigate progression.
• Early recognition and risk stratification of ILA are crucial for improving patient outcomes and potentially preventing severe ILD.